Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$124.05 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 11.23B 9.26B 7.67B 6.49B
Cost of Sales 392.30M 297.10M 274.80M 229.10M
Gross Operating Profit 10.84B 8.96B 7.40B 6.26B
Selling, General, and Administrative Expenses 2.66B 2.31B 2.03B 1.68B
Research & Development 4.47B 3.70B 2.43B 2.23B
Operating Income before D & A (EBITDA) 3.71B 2.96B 2.94B 2.35B
Depreciation & Amortization 504.70M 402.00M 369.40M 374.10M
Interest Income 30.30M 31.10M 28.20M 22.00M
Other Income - Net -362.10M -251.20M -92.40M -245.00M
Special Income / Charges 37.80M 299.60M 48.70M 171.10M
Total Income Before Interest Expenses (EBIT) 2.87B 2.33B 2.50B 1.76B
Interest Expense 500.10M 310.60M 176.10M 91.60M
Pre-Tax Income 2.37B 2.02B 2.33B 1.67B
Income Taxes 373.30M 421.50M 327.50M 215.50M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.00B 1.60B 2.00B 1.45B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.00B 1.60B 2.00B 1.45B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.00B 1.60B 2.00B 1.45B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.00B 1.60B 2.00B 1.45B
Preferred Dividends
Net Income Available To Common 2.00B 1.60B 2.00B 1.45B
Basic EPS from Continuing Ops. 2.57 2.02 2.49 1.75
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.57 2.02 2.49 1.75
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.57 2.02 2.49 1.75
Basic Normalized Net Income/Share 2.57 2.02 2.49 1.75
EPS fr Continuing Ops. 2.49 1.94 2.39 1.68
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.49 1.94 2.39 1.68
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.49 1.94 2.39 1.68
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.49 1.94 2.39 1.68
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter